Arkolith/Insider Trading/HILS/Form 4

Milby Randy

Chief Executive Officer, DirectorHillstream BioPharma Inc. (HILS) · full profile →Form 4 · filed Jan 20, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
29
14 non-derivative · 15 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 14, 2022Conversion(C)35K$3.20$113K2.6M
Jan 14, 2022Conversion(C)3K$3.20$10K2.4M
Jan 14, 2022Conversion(C)11K$3.20$36K2.4M
Jan 14, 2022Conversion(C)8K$3.20$26K2.4M
Jan 14, 2022Conversion(C)31K$3.20$99K2.7M
Jan 14, 2022Conversion(C)31K$3.20$100K2.7M
Jan 14, 2022Conversion(C)10K$3.20$31K2.6M
Jan 14, 2022Conversion(C)26K$3.20$84K2.6M
Jan 14, 2022Conversion(C)12K$3.20$37K2.5M
Jan 14, 2022Conversion(C)22K$3.20$72K2.6M
Jan 14, 2022Conversion(C)29K$3.20$93K2.5M
Jan 14, 2022Conversion(C)28K$3.20$91K2.5M
Jan 14, 2022Conversion(C)19K$3.20$62K2.5M
Jan 14, 2022Conversion(C)10K$3.20$31K2.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Grant(A)0—$0758K
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)0—$00
Jan 14, 2022Conversion(C)758K—$00
Jan 14, 2022Conversion(C)0—$00

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-001680) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML